Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetics of 6-thioguanine in inflammatory bowel disease
NL-OMON23696Active, not recruiting
- Sponsor
- N/A
- Start
- Jun 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of tioguanine in inflammatory bowel disease (IBD), Crohn's disease and autoimmune colitis, sponsored by N/A. Primary endpoint: Determination of first pass effect of 6TG metabolites. Started Jun 2005; status: active, not recruiting.
02
Drugs
tioguanine
03
Conditions
inflammatory bowel disease (IBD)Crohn's diseaseautoimmune colitis
Beyond the preview
Go deeper on NL-OMON23696.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON23696.